| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.7 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.7 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |